The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...

After receiving a diagnosis of terminal cancer, he used his experience in public relations to draw attention to the ...

Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma industry by market cap. | Two investigational cardiometabolic drugs from Eli ...

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

Patients with rheumatoid arthritis (RA) who receive immune checkpoint inhibitor (ICI) therapy for cancer do not appear to face higher mortality compared against patients without RA receiving the same ...

Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP analysis.  The saving ...

Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is developing VK2735, an investigational novel, dual GLP-1 and GIP receptor ...

Medicare Part D coverage is never static, but 2026 is shaping up to be a particularly volatile year for formularies.

LONDON (AP) — Britons ranging from Hollywood stars Idris Elba and Cynthia Erivo to a 102-year-old judo instructor have been named in King Charles III’s New Year’s honors list, an annual tradition that ...